Prevest Denpro Posts Steady Growth in Q1 FY26 with Improved Profitability.

Prevest Denpro delivered a stable performance in the June 2025 quarter, with consistent growth across sales, operating profit, and net earnings. Sales rose 18% YoY to ₹15.7 crore from ₹13.3 crore in June 2024, supported by healthy demand for dental products. EBIDT improved 23% YoY to ₹5.53 crore, up from ₹4.49 crore, reflecting better operating efficiencies. Net profit increased 27% YoY to ₹4.63 crore versus ₹3.65 crore last year, driving EPS higher to ₹3.86 from ₹3.04, marking a 27% YoY growth. On a sequential basis, however, revenue and profitability moderated compared to March 2025, indicating some seasonal or demand normalization. At the current market price of ₹545, Prevest Denpro commands a market capitalization of ₹654 crore and trades at a PE of 34.1, suggesting investors are factoring in steady earnings visibility. Summary: Prevest Denpro continues to deliver consistent double-digit growth in revenue and profitability. While sequential softness is visible, the company’s strong fundamentals and efficient cost management reinforce its position as a steady compounder in the healthcare products space.